Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, December 25, 2009, 9:53PM ET - U.S. Markets Closed for Christmas. Dow Up 0.51% Nasdaq Up 0.71%
VIVUS Inc. (VVUS)On Dec 24: 9.93  Down 0.09 (0.90%)  
MORE ON VVUS
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Mon, Nov 2, 2009
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Nov 2)
Stock Smackdown: Cramer vs. CAPS
at Motley Fool (Mon, Nov 2)
Amylin Makes Obesity Drug Deal: BioBuzz
at TheStreet.com (Mon, Nov 2)
Amylin Strikes First With Obesity Drug Deal
at TheStreet.com (Mon, Nov 2)
Amylin Strikes First With Obesity Drug Deal: BioBuzz
at TheStreet.com (Mon, Nov 2)
Fri, Oct 30, 2009
Friday At The Fat Fight
at CNBC (Fri, Oct 30)
Thu, Oct 29, 2009
Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
PR Newswire (Thu, Oct 29)
Wed, Oct 28, 2009
Vivus, Analyst in Obesity Drug Side-Effect Spat
at TheStreet.com (Wed, Oct 28)
VIVUS Announces Date of Third Quarter 2009 Financial Results and Conference Call
GlobeNewswire (Wed, Oct 28)
Tue, Oct 27, 2009
Cramer's 'Mad Money' Follow-Up: Oct. 27
at TheStreet.com (Tue, Oct 27)
Mon, Oct 26, 2009
Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues
Wall Street Transcript (Mon, Oct 26)
Sector Snap: Obesity drug makers gain ground
AP (Mon, Oct 26)
Vivus' Mr. Wilson Goes To Washington
at CNBC (Mon, Oct 26)
Biotech Stocks: Pharma stocks turn lower; BioCryst, Vivus gain
at MarketWatch (Mon, Oct 26)
[video] Saving Health Care Dollars...and Lives
at CNBC (Mon, Oct 26)
Arena Pharma rises on new lorcaserin trial data
AP (Mon, Oct 26)
[video] Vivus CEO on Diet Drug
at CNBC (Mon, Oct 26)
[video] Trimming the Health Care Fat
at CNBC (Mon, Oct 26)
Tue, Oct 20, 2009
Biotech Mergers And Acquisitions Will Accelerate According To Wedbush Morgan Expert Analyst As More Expensive Phase III Trials Force Small Biotech Companies Into Large Pharma Distribution And Finance Organizations
Wall Street Transcript (Tue, Oct 20)
Mon, Oct 19, 2009
Stock Smackdown: Cramer vs. CAPS
at Motley Fool (Mon, Oct 19)
Sat, Oct 17, 2009
Medicine's Elusive Goal: A Safe Weight-Loss Drug
at The New York Times (Sat, Oct 17)
Assessing the Chances for the Next Wave of Obesity Drugs
at The New York Times (Sat, Oct 17)
Fri, Oct 16, 2009
'Mad Money Lightning Round': Stick With 3M
at TheStreet.com (Fri, Oct 16)
Mon, Oct 12, 2009
[$$] Upbeat Trading in a Thin-Volume Environment
at RealMoney by TheStreet.com (Mon, Oct 12)
Fri, Oct 9, 2009
Biotech Mailbag: Transdel Pharma
at TheStreet.com (Fri, Oct 9)
Older Headlines - Most Recent Headlines
View headlines from:
Add VVUS News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage